Skip to main content
. 2023 May 18;13:1148635. doi: 10.3389/fonc.2023.1148635

Table 7.

Inter-quartile analysis for CTSZ methylation level between BC cases and controls at early stage.

CpG sites Quartiles
(methylation range)
BC cases N (%) controls N (%) Total OR (95%CI) P-value Ptrend
CTSZ_CpG_1 Q4 (> 0.36) 63 (18.8) 152 (23.9) 215 1 <0.001*
Q3 (≤ 0.36) 66 (19.7) 175 (26.6) 241 0.913 (0.604-1.380) 0.667
Q2 (≤ 0.29) 105 (31.3) 165 (25.9) 270 1.503 (1.022-2.211) 0.038*
Q1 (≤ 0.21) 101 (30.2) 143 (22.5) 244 1.526 (1.027-2.265) 0.036*
CTSZ_CpG_3 Q4 (> 0.12) 73 (21.8) 137 (21.6) 210 1 0.010*
Q3 (≤ 0.12) 64 (19.1) 182 (28.7) 246 0.699 (0.461-1.058) 0.090
Q2 (≤ 0.09) 75 (22.4) 150 (23.6) 225 0.968 (0.643-1.455) 0.874
Q1 (≤ 0.07) 123 (36.7) 166 (26.1) 289 1.272 (0.875-1.849) 0.208
CTSZ_CpG_4 Q4 (> 0.19) 88 (26.3) 144 (22.7) 232 1 0.402
Q3 (≤ 0.19) 80 (23.9) 163 (25.7) 243 0.841 (0.574-1.232) 0.375
Q2 (≤ 0.14) 82 (24.5) 161 (25.4) 243 0.795 (0.543-1.163) 0.237
Q1 (≤ 0.09) 85 (25.3) 167 (26.2) 252 0.821 (0.562-1.199) 0.308
CTSZ_CpG_5 Q4 (> 0.20) 59 (17.6) 175 (27.6) 234 1 <0.001*
Q3 (≤ 0.20) 74 (22.1) 152 (23.9) 226 1.449 (0.963-2.179) 0.075
Q2 (≤ 0.16) 93 (27.7) 155 (24.4) 248 1.687 (1.137-2.504) 0.009*
Q1 (≤ 0.12) 109 (32.6) 153 (24.1) 262 1.815 (1.217-2.707) 0.003*
CTSZ_CpG_6 Q4 (> 0.35) 85 (22.9) 146 (22.8) 231 1 0.075
Q3 (≤ 0.35) 61 (26.8) 170 (19.4) 231 0.685 (0.457-1.027) 0.067
Q2 (≤ 0.28) 79 (27.1) 172 (25.6) 251 0.859 (0.584-1.263) 0.439
Q1 (≤ 0.22) 110 (23.2) 147 (32.2) 257 1.315 (0.909-1.901) 0.146
CTSZ_CpG_7.8 Q4 (> 0.21) 75 (25.4) 149 (23.5) 224 1 0.045*
Q3 (≤ 0.21) 69 (20.6) 164 (25.8) 233 0.980 (0.650-1.478) 0.924
Q2 (≤ 0.17) 68 (20.3) 141 (22.2) 209 1.174 (0.769-1.793) 0.458
Q1 (≤ 0.14) 123 (36.7) 181 (28.5) 304 1.579 (1.078-2.312) 0.019*
CTSZ_CpG_9.10 Q4 (> 0.40) 78 (23.3) 159 (25.0) 237 1 0.131
Q3 (≤ 0.40) 67 (20.0) 152 (23.9) 219 0.946 (0.634-1.410) 0.784
Q2 (≤ 0.34) 84 (25.1) 150 (23.6) 234 1.156 (0.787-1.697) 0.459
Q1 (≤ 0.28) 106 (31.6) 174 (27.4) 280 1.165 (0.804-1.688) 0.419

*Statistically significant.